Phaeochromocytoma: A case study

Clinical Chiropractic

Volumn 6, Issue 2, 2003, Pages 50-54

  Foggo, Jason ^a  

^a Sutton Chiropractic Clinic   (United Kingdom)

Author keywords

Adult; Chiropractic; Human; Phaeochromocytoma

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; FEMALE; FOLLOW UP; HUMAN; MUSCULOSKELETAL DISEASE; PHEOCHROMOCYTOMA; TUMOR DIAGNOSIS;

EID: 15944409499     PISSN: 14792354     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1479-2354(02)00005-6     Document Type: Article

References (36)

1. Walther MM, Keiser HR, Linehan WM. Pheochromocytoma: evaluation, diagnosis, and treatment. World J Urol 1999;17:35-9.
2. Bravo EL, Gilford Jr RW. Pheochromocytoma: diagnosis, localization and management. New Engl J Med 1984;311:1298-303.
3. Cryer PE. Phacochromocytoma. Clin Endocrinol Metab 1985;14:203-20.
4. Plouin PF, Chatellier G, Rougeot MA, Duclos JM, Pagny JY, Corvol P, et al. Recent developments in pheochromocytoma diagnosis and imaging. Adv Nephrol Necker Hosp 1988;17:275-86.
5. Fonseca V, Bouloux PM. Phacochromocytoma and paraganglioma. Bailliere's Clin Endocrinol Metab 1993;7:509-44.
6. Manger WM, Gifford Jr RW. Pheochromocytoma: current diagnosis and management. Cleve Clin J Med 1993;60:365-78.
7. Gavaghan M. Surgical treatment of pheochromocytomas. AORN J 1997;65:1041-51; passim; quiz 1072-80.
8. Yong Jr WF. Pheochromocytoma and primary aldosteronism: diagnostic approaches. Endocrinol Metab Clin North Am 1997;26:801-27.
9. Stenstroem G, Svardsudd K. Pheochromocytoma in Sweden 1958-1981. An analysis of the National Cancer Registry Data. Acta Med Scand 1986;220:225-32.
10. Van Heerden JA. First encounters with pheochromocytoma. The story of Mother Joachim. Am J Surg 1982;144:277-9.
11. Gifford RW, Kvale WF, Maher FT. Clinical features, diagnosis and treatment of pheochromocytoma: a review of 76 cases. Mayo Clin Proc 1964;39:281-302.
12. Manger WM, Gifford RW. Clinical and experimental pheochromocytoma, 2nd ed. Cambridge, MA: Blackwell Science; 1996. p. 333-65.
13. Lenders JW, Keiser HR, Goldstein DS. Plasma metanephrines in the diagnosis of pheochromocytoma. Ann Intern Med 1995;123:101-9.
14. Eisenhofer G, Lenders JW, Linehan WM. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Nippel-Lindau disease and multiple endocrine neoplasia type 2. New Engl J Med 1999;340:1872-9.
15. Goldstein DS, Stull R, Eisenhofer G, Sisson JC, Weder A, Averbuch SD, et al. Plasma 3,4-dihydroxyphenylalanine (DOPA) and catecholamines in neuroblastoma or pheochromocytoma. Ann Intern Med 1986;105:887-9.
16. Keiser HR, Goldstein DS, Averbuch SD. Treatment of malignant pheochromocytoma with combination chemotherapy. Hypertension 1985;7(Suppl. I):I18-24.
17. Averbuch SD, Steakley CS, Keiser HR. Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide vincristine and dacarbazine. Ann Intern Med 1988;109:267-73.
18. Manger WM, Gifford RW. Pheochromocytoma. J Clin Hypertens (Greenwich) 2002;4:62-72.
19. Shapiro B, Gross MD, Shulkin B. Radioisotope diagnosis and therapy of malignant pheochromocytoma. Trends Endocrinol Metab 2001;12:469-75.
20. Suzuki K. Surgical management of pheochromocytoma. Biomed Pharmacother 2000;54(Suppl 1):150s-6s.
21. Werbel SS, Ober KP. Pheochromocytoma. Update on diagnosis, localization, and management. Med Clin North Am 1995;79:131-53.
22. Beatty OL, Russell CF, Kennedy L, Hadden DR, Kennedy TL, Atkinson AB. Phaeochromocytoma in Northern Ireland: a 21 year review. Eur J Surg 1996;162:695-702.
23. Ram CV, Fierro-Carrion GA. Pheochromocytoma. Semin Nephrol 1995;15:126-37.
24. Gifford Jr RW, Manger WM, Bravo EL. Pheochromocytoma. Endocrinol Metab Clin North Am 1994;23:387-404.
25. Kenady DE, McGrath PC, Sloan DA, Schwartz RW. Diagnosis and management of pheochromocytoma. Curr Opin Oncol 1997;9:61-7.
26. Lucon AM, Pereira MA, Mendonca BB, Halpern A, Wajchenbeg BL, Arap S. Pheochromocytoma: study of 50 cases. J Urol 1997;157:1208-12.
27. Bravo EL. Evolving concepts in the pathophysiology, diagnosis and treatment of pheochromocytoma. Endocr Rev 1994;15:356.
28. Bravo EL, Sahag GOR. Preoperative localization of pheochromocytoma: a prospective comparison of lodo-131-metaiodobenzylquanidine and abdominal computed tomography. Read at European Meeting on Hypertension, June 1989; Milan, Italy (abstract 122).
29. Pocaro AB, Cavalleri S, Ballista C, Righetti R, Ficarra V, Malossini G, et al. Modern imaging methods and preoperative management of pheochromocytoma: review of the literature and case report. Arch Esp Urol 2000;53:749-53.
30. Eisenhofer G, Lenders JWM, Linehan WM, Walther MM, Goldstein DS, Keiser HR. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in Von Hippel-Lindau disease and multiple endocrine neoplasia type 2. New Engl J Med 1999;340:1872-9.
31. Minno AM, Bennett WA, Kvale WF. Pheochromocytoma: a study of 15 cases diagnosed at autopsy. New Engl J Med 1954;251:959-65.
32. Bravo EL, Gifford RW. Pheochromocytoma: diagnosis, location and management. New Engl J Med 1984;311:1298-303.
33. O'Connor DT. Adrenal medulla. In: Plum F, Bennett C, editors. Cecil textbook of medicine, 20th ed. Philadelphia, PA: WB Saunders; 1996. p. 1253-7.
34. Manger WM, Gifford RW. Pheochromocytoma. New York: Springer; 1977.
35. Duncan MW, Compton P, Lazarus L, Smythe GA. Measurement of nor-epinephrine and 34-dihydroxyphenylgylcol in urine and plasma for diagnosis of pheochromocytoma. New Engl J Med 1988;319:136-42.
36. Gitlow SE, Mendlowitz M, Bertani LM. Biochemical techniques for detecting and establishing the presence of pheochromocytoma: a review of 10 years' experience. Am J Cardiol 1970;26:270-9.